Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 29, 2021
[Radiation Protection Against Exposure from Patients Receiving 131I-MIBG and Released from Radiation Treatment Room]Anri Inaki, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|September 26, 2024
Recent advancements in new tracers from first-in-human studiesYuji Nakamoto, Yoshitaka Inui, Masatoshi Hotta, et al.
Nuklearmedizin. Nuclear Medicine|June 7, 2022
I-131 metaiodobenzylguanidine therapy is a significant treatment option for pheochromocytoma and paragangliomaXue Zhang, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|January 16, 2018
Is 123I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal databaseKenichi Nakajima, Koichi Okuda, Shinro Matsuo, et al.
Seminars in Nuclear Medicine|January 14, 2023
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and ParagangliomaXue Zhang, Hiroshi Wakabayashi, Tomo Hiromasa, et al.
Annals of Nuclear Medicine|July 19, 2019
Fully automated analysis for bone scintigraphy with artificial neural network: usefulness of bone scan index (BSI) in breast cancerAnri Inaki, Kenichi Nakajima, Hiroshi Wakabayashi, et al.
European Thyroid Journal|March 11, 2025
Enhancing radioactive iodine (RAI) incorporation in RAI-refractory differentiated thyroid cancer: current insightsTomo Hiromasa, Hiroshi Wakabayashi, Satoru Watanabe, et al.
Annals of Nuclear Medicine|April 17, 2020
Radiation exposure in nurses during care of 131I-MIBG therapy for pediatric patients with high-risk neuroblastomaYuka Taniguchi, Hiroshi Wakabayashi, Anri Inaki, et al.
Pageof 12